Deucrictibant IR Capsule
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Deucrictibant IR Capsule, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency [Phase 3]